tsla

Stocks With Major Move: Cooper Tire & Rubber Co. (NYSE:CTB), Leggett & Platt, Incorporated (NYSE:LEG), Tesla Motors Inc (NASDAQ:TSLA)

Cooper Tire & Rubber Co. (NYSE:CTB) [Trend Analysis] reported on Friday that its Q1 profit of $40.8M. On a per-share basis, the Findlay, Ohio-based firm reported that it had More...

Stock Busy in Financial Matters: JPMorgan Chase & Co. (NYSE:JPM), Lifepoint Hospitals Inc. (NASDAQ:LPNT), Ford Motor Co. (NYSE:F)

JPMorgan Chase & Co.’s (NYSE:JPM) [Trend Analysis] consumer website experienced bouts of sometimes paralyzing sluggishness Friday. But officials are blaming the date, More...

News In Reviews: The Goldman Sachs Group, Inc. (NYSE:GS), Duke Energy Corporation (NYSE:DUK), Berkshire Hathaway Inc. (NYSE:BRK-B)

Jurors who convicted ex- The Goldman Sachs Group, Inc. (NYSE:GS) [Trend Analysis] programmer Sergey Aleynikov said they struggled to find a crime in his copying of the bank’s More...

Technical Summary Widget Powered by Investing.com
stock earnings

Impact of News on Stocks: Ocwen Financial Corp. (N...

Ocwen Financial Corp. (NYSE:OCN) [Trend Analysis] released that its preliminary net income of $34.4M, or $0.27 per share, for the three months ended March 31, 2015 as compared to net income of $60.5M, or $0.43 per share, for the three months ended March More...

 
stocks

Consumer’s Goods Stocks: Mondelez International,...

Mondelez International, Inc. (NASDAQ:MDLZ) [Trend Analysis] reported a socially charged campaign to rally consumers and fans across the country to share a message of support for the U.S. Women’s National Team as the squad prepares to compete in More...

 
stocks

Healthcare Stocks: AbbVie Inc. (NYSE:ABBV), Pernix...

AbbVie Inc. (NYSE:ABBV) [Trend Analysis] reported on Friday that it is again expanding its exchange offer to buy cancer biotech Pharmacyclics Inc. in a cash-and-stock deal valued at $21 billion. The pharmaceutical giant, which last year called off a deal More...

 
stocks news

Healthcare on Active Notes: Celgene Corporation (N...

Celgene Corporation (NASDAQ:CELG) [Trend Analysis] announced results from a pre-specified secondary endpoint analysis of MDS-005, a multicenter, randomized, placebo controlled phase III study of REVLMID® (lenalidomide) compared with placebo in patients More...